Effector Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Effector Therapeutics shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Effector Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Effector Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Effector Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $269k | 574k | 0.47 |
| 2023-09-30 | $242k | 404k | 0.60 |
| 2023-06-30 | $337k | 406k | 0.83 |
| 2023-03-31 | $143k | 406k | 0.35 |
| 2022-12-31 | $184k | 429k | 0.43 |
| 2022-06-30 | $734k | 517k | 1.42 |
| 2022-03-31 | $2.1M | 517k | 4.01 |
Top funds holding Effector Therapeutics
View all funds holding Effector Therapeutics